Arrhythmic risk stratification of post-myocardial infarction patients

Current Opinion in Cardiology

Volumn 15, Issue 1, 2000, Pages 1-6

  Naccarella, Franco ^a,c   Lepera, Giovannina ^a   Rolli, Angelo ^b  

^a Divisione di Cardiologia   (Italy)

^b Divisione di Cardiologia   (Italy)

^c Cardiologia Bologna   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ACUTE HEART INFARCTION; CLINICAL TRIAL; HEART ARRHYTHMIA; HEART EJECTION FRACTION; HEART INFARCTION; HEART RATE VARIABILITY; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE TACHYCARDIA; HUMAN; MORTALITY; PATIENT SELECTION; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SIGNAL AVERAGED ELECTROCARDIOGRAPHY; SUDDEN DEATH; T WAVE;

AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIA; DEATH, SUDDEN, CARDIAC; ELECTROPHYSIOLOGY; HUMANS; MYOCARDIAL INFARCTION; RISK FACTORS;

EID: 0033955799     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001573-200001000-00001     Document Type: Review

References (29)

1. 1 Naccarella F, Bracchetti D, Palmieri M, Barbato G: Arrhythmic risk stratification in post acute myocardial infarction: role of non invasive and invasive procedures: new perspective. New Trends Arrhythmias 1993, IX:41-51.
2. 2 Salerno-Uriarte JA: La stratificazione del rischio aritmico nel postinfarto: ritorno in auge di una moda obsoleta o effettiva necessità clinica? Cardiologia 1999, 26:1169-1175.
3. 3 Franzosi MG, Santoro E, De Vita C, Geraci E, Lotto A, Maggioni AP, et al., on behalf of the GISSI Investigators: Ten-year follow-up of the first mega-trial testing thrombolytic therapy in patients with acute myocardial infarction: results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto-1 Study. Circulation 1998, 98:2659-2665. This article is important because the incidence and the prognostic significance of post-AMI ventricular arrhythmias changed in some way, after the widespread use of fibrinolytic therapy in post-AMI patients.
4. 4 Newby KH, Thompson T, Stebbins A, Topol EJ, Califf RM, Natale A, for the GUSTO Investigators: Sustained ventricular arrhythmias in patients receiving thrombolytic therapy: incidence and outcomes. Circulation 1998, 98:2567-2573. See [3·].
5. 5 Maggioni AP, Zuanetti G, Franzosi MG, Rovelli F, Santoro E, Staszewsky L, et al., on behalf of GISSI-2 Investigators: Prevalence and prognostic significance of ventricular arrhythmias after acute myocardial infarction in the fibrinolytic era: GISSI-2 results. Circulation 1993, 87:312-322.
6. 6 Volpi A, De Vita C, Franzosi AM, Geraci E, Maggioni AP, Mauri F, et al., for the Ad Hoc Working Group of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-2 Data Base: Determinants of 6-month mortality in survivors of myocardial infarction after thrombolysis: results of the GISSI-2 data base. Circulation 1993, 88:416-429.
7. 7 Richards DAB, Byth K, Ross DL, Uther JB: What is the best predictor of spontaneous ventricular tachycardia and sudden death after myocardial infarction? Circulation 1991, 83:756-763.
8. 8 Kulakowski P, Malik M, Poloniecki J, Bashir Y, Odemuyiwa O, Farrell T, et al.: Frequency versus time domain analysis of signal-averaged electrocardiograms: II: identification of patients with ventricular tachycardia after myocardial infarction. J Am Coll Cardiol 1992, 20:135-143.
9. 9 Odemuyiwa O, Malik M, Farrell T, Bashir Y, Poloniecki J, Camm J: Comparison of the predictive characteristics of heart rate variability index and left ventricular ejection fraction for all-cause mortality, arrhythmic events and sudden death after acute myocardial infarction. Am J Cardiol 1991, 68:434-439.
10. 10 La Rovere MT, Bigger JT Jr, Marcus FI, Mortara A, Schwartz PJ, for the ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators: Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. Lancet 1998, 351:478-484. Shows the importance of reduced HRV and baroreflex sensitivity in post-AMI ARS. The association of reduced HRV and EF% less than 30% is even more powerful.
11. 11 Martini-Rubio A, Shenasa M, Borggrefe M, Chen X, Benning F, Breithardt G: Electrophysiologic variables characterizing the induction of ventricular tachycardia versus ventricular fibrillation after myocardial infarction: relation between ventricular late potentials and coupling intervals for the induction of sustained ventricular tachyarrhythmias. J Am Coll Cardiol 1993, 21:1642-1631.
12. 12 Bourcke JP, Richards DAB, Ross DL, Wallace EM, McGuire MA, Uther JB: Routine programmed electrical stimulation in survivors of acute myocardial infarction for prediction of spontaneous ventricular tachyarrhythmias during follow-up: results, optimal stimulation protocol and cost-effective screening. J Am Coll Cardiol 1991, 18:780-788.
13. 13 Platt SB, Vijgen JM, Albrecht P, van Hare GF, Carlson MD, Rosenbaum DS: Occult T wave alternans in long QT syndrome. J Cardiovasc Electrophysiol 1996, 7:144-148.
14. 14 Rosenbaum DS, Albrecht P, Cohen RJ: Predicting sudden cardiac death from T wave alternans of the surface electrocardiogram: promise and pitfalls. J Cardiovasc Electrophysiol 1996, 7:1095-1111.
15. 15 Estes NAM III, Michaud G, Zipes DP, El-Sherif N, Venditti FJ, Rosenbaum DS, et al.: Electrical alterations during rest and exercise as predictors of vulnerability to ventricular arrhythmias. J Am Coll Cardiol 1997, 80:1314-1318.
16. 16 Armoundas AA, Rosenbaum DS, Ruskin JN, Garan H, Cohen RJ. Prognostic significance of electrical alternans versus signal-averaged electrocardiography in predicting the outcome of electrophysiological testing and arrhythmia-free survival. Heart 1998, 80:251-256.
17. 17 Hohnloser SH, Klingenheben T, Li YG, Zabel M, Peetermans J, Cohen RJ: T wave alternans as a predictor of recurrent ventricular tachyarrhythmias in ICD recipients: prospective comparison with conventional risk markers. J Cardiovasc Electrophysiol 1998, 9:1258-1268.
18. 18 Bigger JT Jr, for the Coronary Artery Bypass Graft (CABG) Patch Trial Investigators: Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary artery bypass graft surgery. N Engl J Med 1997, 337:1569-1575.
19. 19 Farrell TG, Bashir Y, Malik M, Poloniecki J, Bennett ED, Ward DE, Camm AJ: Risk stratification for arrhythmic events based on heart rate variability, ambulatory electrocardiographic variables and the signal averaged electrocardiogram. J Am Coll Cardiol 1991, 18:687-697.
20. 20 Odemujiawa O, Malik M, Farrell T, Camm AJ: Comparison of the predictive characteristics of heart rate variability index and left ventricular ejection fraction for all-cause mortality, arrhythmic events and sudden death after acute myocardial infarction. Am J Cardiol 1991, 68:434-439.
21. 21 Bigger JT, Fleiss JL, Roinitzky LM, Steinman RC: Frequency domain measures of heart period variability to assess risk late after myocardial infarction. J Am Coll Cardiol 1993, 21:729-736.
22. 22 Pedretti R, Colombo E, Sarzi Braga S, Carù B: Effect of thrombolysis on heart rate variability and life-threatening ventricular arrhythmias in survivors of acute myocardial infarction. Int J Cardiol 1994, 23:19-26.
23. 23 Roy D, Marchand E, Théroux P, Waters DD, Pellettier GB, Bourassa MG: Programmed ventricular stimulation in survivors of an acute myocardial infarction. Circulation 1985, 72:487-494.
24. 24 Bourke JP, Young AA, Richards DA, Uther JB: Reduction in incidence of inducible ventricular tachycardia after myocardial infarction by treatment with streptokinase during infarct evolution. J Am Coll Cardiol 1990, 16:1703-1710.
25. 25 Hii JTY, Traboulsi M, Mitchell LB, Wyse DG, Duff HJ, Gillis AM: Infarct artery patency predicts outcome of serial electropharmacological studies in patients with malignant ventricular tachyarrhythmias. Circulation 1993, 87:764-772.
26. 26 Pedretti R, Etro MD, Laporta A, Braga SS, Carù B: Prediction of late arrhythmic events after acute myocardial infarction from combined use of noninvasive prognostic variables and inducibility of sustained monomorphic ventricular tachycardia. Am J Cardiol 1993, 71:1131-1141.
27. 27 Lee KL, Buxton AE, Hafley GE, Fisher JD: EP-guided therapy reduces the risk of arrhythmic events due to the use of ICDS, but not antiarrhythmic drugs: results from MUSTT. Circulation 1999, 100(suppl 1):I-80-81.
28. 28 Raviele A, Bongiorni MG, Brignole M, Cappato R, Capucci A, Gaita F, et al.: Which strategy is "best" after myocardial infarction? The Beta-Blocker Strategy Plus Implantable Cardioverter Defibrillator Trial: rationale and study design. Am J Cardiol 1999, 83:104D-111D. This article represents a prospective ongoing protocol that will assess the usefulness of ICD in medium-high-risk post-AMI patients (different subgroups) selected on the basis of an increased risk of sudden death (the BEST ICD study).
29. 29 Klein H, Auricchio A, Reek S, Geller C: New primary prevention trials of sudden cardiac death in patients with left ventricular dysfunction: SCD-HEFT and MADIT-II. Am J Cardiol 1999, 83:91D-97D. This article refers to two studies assessing the usefulness of ICD in post-AMI patients with reduced EF% (MADIT II) and in patients with congestive heart failure, New York Heart Association II and III (SCD-HeFT).